Ascendis Pharma A/S (ASND) Stock Chart & Stock Price History $172.60 +0.38 (+0.22%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ascendis Pharma A/S Stock Price Performance The Ascendis Pharma A/S (ASND) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 28.83%, with a year-to-date return of 25.37%. In the past month, the stock has increased 5.64%, reflecting recent market activity. As of the latest close, Ascendis Pharma A/S traded at $172.60 with a market cap of $10.55 billion and volume of 420,195 shares. Five years ago, the stock traded at $147.90, representing a 16.70% increase over that period. At the time, it had a market cap of $6.97 billion and a volume of 178,900 shares. Receive ASND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.20%1 Month Performance+5.64%3 Month Performance+13.98%Year-To-Date Performance+25.37%1 Year Performance+28.83%5 Year Performance+16.70% ASND Stock Chart for Tuesday, July, 1, 2025 ASND Chart by TradingView Ascendis Pharma A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$172.22$172.60+0.22%$174.31$169.21420,195 shs$10.55 billion06/27/2025$172.95$172.22-0.42%$174.81$170.67255,335 shs$10.53 billion06/26/2025$173.00$172.95-0.03%$175.27$172.00353,316 shs$10.57 billion06/25/2025$179.10$173.00-3.41%$179.20$166.84641,895 shs$10.58 billion06/24/2025$175.78$179.10+1.89%$180.78$175.54377,009 shs$10.95 billion06/23/2025$176.90$175.78-0.63%$179.20$174.53399,955 shs$10.75 billion06/20/2025$170.71$176.90+3.63%$177.21$170.37415,686 shs$10.81 billion06/19/2025$170.71$170.71$175.28$170.49288,936 shs$10.44 billion06/18/2025$172.90$170.71-1.27%$175.28$170.49288,936 shs$10.44 billion06/17/2025$177.71$172.90-2.71%$178.62$172.35394,805 shs$10.56 billion Get the Latest News and Ratings for ASND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$170.80$177.71+4.05%$178.18$169.90452,056 shs$10.86 billion06/13/2025$170.92$170.80-0.07%$173.82$169.65369,830 shs$10.43 billion06/12/2025$171.72$170.92-0.47%$174.08$169.75249,897 shs$10.44 billion06/11/2025$172.35$171.72-0.37%$174.11$170.69231,952 shs$10.47 billion06/10/2025$173.15$172.35-0.46%$175.35$170.18380,950 shs$10.51 billion06/09/2025$173.06$173.15+0.05%$177.06$172.00484,693 shs$10.56 billion06/06/2025$177.55$173.06-2.53%$178.12$171.55595,956 shs$10.55 billion06/05/2025$173.69$177.55+2.22%$177.83$167.55358,045 shs$10.83 billion06/04/2025$174.40$173.69-0.41%$177.97$168.11537,095 shs$10.59 billion06/03/2025$175.69$174.40-0.73%$179.40$172.60567,085 shs$10.63 billion06/02/2025$163.38$175.69+7.53%$177.94$165.02950,818 shs$10.71 billion05/30/2025$163.57$163.38-0.12%$165.67$162.70368,695 shs$9.96 billion Related Companies ARGX Stock Chart ONC Stock Chart BNTX Stock Chart TEVA Stock Chart SMMT Stock Chart ITCI Stock Chart GMAB Stock Chart RDY Stock Chart VTRS Stock Chart QGEN Stock Chart Receive ASND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ASND) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
